FDA Approved: VELSIPITY — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved Pfizer's supplemental application for VELSIPITY (etrasimod), resulting in updated labeling and/or indication for ulcerative colitis under NDA 21695…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VELSIPITY (ETRASIMOD)

Snippet

SUPPL AP for VELSIPITY (ETRASIMOD)